GB202405758D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB202405758D0 GB202405758D0 GBGB2405758.0A GB202405758A GB202405758D0 GB 202405758 D0 GB202405758 D0 GB 202405758D0 GB 202405758 A GB202405758 A GB 202405758A GB 202405758 D0 GB202405758 D0 GB 202405758D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2405758.0A GB202405758D0 (en) | 2024-04-24 | 2024-04-24 | Compounds |
| PCT/EP2025/061121 WO2025224196A1 (en) | 2024-04-24 | 2025-04-23 | Compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2405758.0A GB202405758D0 (en) | 2024-04-24 | 2024-04-24 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202405758D0 true GB202405758D0 (en) | 2024-06-05 |
Family
ID=91275270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2405758.0A Pending GB202405758D0 (en) | 2024-04-24 | 2024-04-24 | Compounds |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB202405758D0 (en) |
| WO (1) | WO2025224196A1 (en) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US6150090A (en) | 1986-01-09 | 2000-11-21 | Massachusetts Institute Of Technology | Nuclear factors associated with transcriptional regulation |
| UA56132C2 (en) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Vaccine composition (variants), method for stabilizing qs21 providing resistance against hydrolysis (variants), method for manufacturing vaccine |
| GB0226593D0 (en) | 2002-11-14 | 2002-12-24 | Consultants Ltd | Compounds |
| GB0404574D0 (en) * | 2004-03-01 | 2004-04-07 | Spirogen Ltd | Amino acids |
| NZ553500A (en) | 2004-09-23 | 2009-11-27 | Genentech Inc Genentech Inc | Cysteine engineered antibodies and conjugates withCysteine engineered antibodies and conjugates with a free cysteine amino acid in the heavy chain a free cysteine amino acid in the heavy chain |
| WO2007039752A1 (en) | 2005-10-05 | 2007-04-12 | Spirogen Limited | Alkyl 4- [4- (5-oxo-2, 3, 5, 11a-tetrahyd0-5h-pyrr0l0 [2, 1-c] [1, 4] benzodiazepine-8-yloxy) -butyrylamino]-1h-pyrrole-2-carboxylate derivatives and related compounds for the treatment of a proliferative disease |
| CL2008001334A1 (en) | 2007-05-08 | 2008-09-22 | Genentech Inc | ANTI-MUC16 ANTIBODY DESIGNED WITH CISTEINE; CONJUGADO THAT UNDERSTANDS IT; METHOD OF PRODUCTION; PHARMACEUTICAL FORMULATION THAT UNDERSTANDS IT; AND ITS USE TO TREAT CANCER. |
| AU2008312457B2 (en) | 2007-10-19 | 2014-04-17 | Genentech, Inc. | Cysteine engineered anti-TENB2 antibodies and antibody drug conjugates |
| BR112014027143B1 (en) | 2012-04-30 | 2020-06-09 | Medimmune Ltd | pyrrolobenzodiazepines |
| GB201900929D0 (en) * | 2019-01-23 | 2019-03-13 | King S College London | Nf-kappa b inhibitors |
-
2024
- 2024-04-24 GB GBGB2405758.0A patent/GB202405758D0/en active Pending
-
2025
- 2025-04-23 WO PCT/EP2025/061121 patent/WO2025224196A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025224196A1 (en) | 2025-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202501331D0 (en) | Compounds | |
| GB202501329D0 (en) | Compounds | |
| GB202500897D0 (en) | Compounds | |
| GB202500755D0 (en) | Compounds | |
| GB202500764D0 (en) | Compounds | |
| GB202500762D0 (en) | Compounds | |
| GB202500761D0 (en) | Compounds | |
| GB202500496D0 (en) | Compounds | |
| GB202500342D0 (en) | Compounds | |
| GB202418679D0 (en) | Compounds | |
| GB202417520D0 (en) | Compounds | |
| GB202417516D0 (en) | Compounds | |
| GB202416725D0 (en) | Compounds | |
| GB202416563D0 (en) | Compounds | |
| GB202416444D0 (en) | Compounds | |
| GB202415958D0 (en) | Compounds | |
| GB202415868D0 (en) | Compounds | |
| GB202412967D0 (en) | Compounds | |
| GB202412846D0 (en) | Compounds | |
| GB202412852D0 (en) | Compounds | |
| GB202412861D0 (en) | Compounds | |
| GB202412857D0 (en) | Compounds | |
| GB202412850D0 (en) | Compounds | |
| GB202412842D0 (en) | Compounds | |
| GB202412849D0 (en) | Compounds |